Organization · Venture Studio
Cube Labs
Cube Labs is an Italian venture builder focused on healthcare technology, creating companies from advanced academic research. They provide support throughout the lifecycle of their ventures and are publicly listed on Euronext Growth Milan.
Overview
What Cube Labs does
What Cube Labs is
Cube Labs is an Italian venture builder focused on healthcare technology, creating companies from advanced academic research. They provide support throughout the lifecycle of their ventures and are publicly listed on Euronext Growth Milan.
How it participates in the startup ecosystem
The current public profile supports funder and program host and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Structured capabilities
- Funder · Program host · Event host · Publisher
- Last reviewed
- March 27, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Cube Labs elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cube Labs as a funder
Investment thesis
Cube Labs is dedicated to bridging the gap between advanced academic science and the commercial life sciences market by creating new companies based on promising R&D activities.
Focus narrative
Cube Labs invests in various sectors within the healthcare technology space, including pharmaceuticals, biotechnology, nutraceuticals, R&D technology, and medical technology. The organization aims to meet global healthcare demands by strategically investing in the development of cutting-edge technologies with strong commercial potential.
Value beyond capital
Cube Labs provides strategic, entrepreneurial, and operational support to its portfolio companies, helping them navigate the lifecycle of development and commercialization in the healthcare technology sector.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Regions
- Europe · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Cube Labs has developed several spin-off companies, including Adamas Biotech, which focuses on innovative solutions for gut health; Bio Aurum, engaged in advanced ocular analysis systems; Biodiapers, which develops innovative absorbent articles for fecal separation; Cartilago, working on technologies related to cartilage repair; FluoDetect, specializing in fluorescence detection technologies; Lipovexa, addressing metabolic disorders; Myrtoviva, focusing on health solutions from natural sources; Regenerabioma, developing regenerative medicine technologies; Skin Plastic Lab, innovating in skin health; and Chromapatch, working on advanced patch technologies for medical applications.
Capability profile
Cube Labs as a program host
Program thesis
Cube Labs is an Italian venture builder in the healthcare technology sector, established to bridge the gap between advanced academic science and the commercial life sciences market.
Focus narrative
Cube Labs invests in various sectors within healthcare technology, including Pharmaceuticals, Biotechnology (BioTech), Nutraceuticals, R&D Technology / Artificial Intelligence (AI), and Medical Technology (MedTech). The organization aims to strategically develop technologies that address global healthcare challenges.
Value and support
Cube Labs offers strategic, entrepreneurial, and operational support to its ventures, helping them navigate the lifecycle from concept to commercialization. This includes access to a network of experts and resources in the healthcare technology sector.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator
- Regions
- Europe
Alumni and track record
Alumni context
Cube Labs has developed several spin-off companies, including Adamas Biotech, which focuses on gut health solutions; Bio Aurum, which specializes in ocular analysis systems; and Regenerabioma, which develops regenerative medicine technologies.
Capability profile
Cube Labs as an event host
Event focus
Cube Labs is dedicated to bridging the gap between advanced academic science and the commercial life sciences market. The organization focuses on creating new companies based on promising research and development (R&D) activities, providing strategic, entrepreneurial, and operational support throughout their lifecycle. Cube Labs aims to meet global healthcare demands by strategically investing in the development of cutting-edge technologies with strong commercial potential.
Format and cadence
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
- Next recorded event
- June 20, 2024
- Next event location
- Rome
Audience and fit
- Sectors
- Pharma Tech · Biotech · Health Data · Health Platforms
- Regions
- Europe
Capability profile
Cube Labs as a publisher
Editorial focus
Cube Labs is a venture builder focused on bridging the gap between advanced academic science and the commercial life sciences market. The organization invests in various sectors within healthcare technology, including pharmaceuticals, biotechnology, nutraceuticals, R&D technology, and medical technology, aiming to meet global healthcare demands through strategic investments in cutting-edge technologies.
Audience value
Cube Labs provides strategic, entrepreneurial, and operational support to new companies based on promising research and development activities, helping to bring innovative healthcare solutions to market.
Format and cadence
- Content formats
- newsletter and blog
- Primary platform
- Website
- Cadence
- regular
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Founders · Investors
- Regions
- Europe
Flagship work and coverage
Flagship properties
Cube Labs publishes newsletters and press releases to provide regular updates on company activities and achievements, along with articles and reports on advancements in healthcare technology and innovation.
Notable coverage
Cube Labs is a flagship partner for the Prix Galien International 2024, a prestigious event recognizing excellence in pharmaceutical and life sciences innovation.
Common questions
What to know about Cube Labs
Upseed classifies Cube Labs under the Venture Studio organization type. Its current public profile includes funder, program host, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.